Source: Shaoxing CDC

\1. Cause of disease

\2. symptoms

\3. infectivity

\4. High risk groups

\5. incubation period

\6. treatment

\7. prevention

\1. Cause of disease

Tuberculosis: Mycobacterium tuberculosis, belonging to bacterial infection.

2019 novel coronavirus: a new coronavirus, which belongs to viral infection.

Mycobacterium tuberculosis

novel coronavirus

\2. symptoms

Tuberculosis: the main symptoms are continuous cough and expectoration for more than 2 weeks. Some patients have hemoptysis, low fever in the afternoon, night sweat, fatigue, emaciation, chest pain, dyspnea, etc.

2019 coronavirus disease: fever (mostly high fever), asthenia, dry cough, and gradually dyspnea are the main manifestations. A few patients are accompanied by symptoms such as nasal congestion, runny nose, diarrhea, and some patients are only characterized by low fever and slight asthenia.

\3. infectivity

Both are infectious.

Tuberculosis: it is mainly spread by droplets. Tuberculosis patients spread it to others by spitting, coughing, sneezing or spraying droplets with Mycobacterium tuberculosis when talking loudly.

2019 coronavirus disease: mainly transmitted by droplets and contact, but it has not been determined whether it can be transmitted through fecal mouth.

\4. High risk groups

Tuberculosis: the population is generally susceptible, and the following 7 groups are high-risk groups of tuberculosis: close contacts of infectious tuberculosis patients, people with low immunity, patients receiving biological agents / immunosuppressants, HIV / AIDS population, diabetes patients, pneumoconiosis patients, other special groups.

2019 coronavirus disease: the population is generally susceptible, the elderly and those with basic diseases are seriously ill after infection, and children and infants are also ill.

\5. incubation period

Both of them have incubation period, but the difference is that the incubation period of tuberculosis may be very long, or even lifelong, and the incubation period of tuberculosis is generally considered to be non infectious; while the incubation period of 2019 coronavirus disease is generally 2-14 days, and the incubation period of some infected persons has been infectious.

\6. treatment

Tuberculosis: it is mainly treated with drugs. There are more than 20 kinds of anti tuberculosis drugs, including first-line anti tuberculosis drugs and second-line anti tuberculosis drugs. Moreover, the treatment cycle of tuberculosis is relatively long, which generally requires at least half a year of continuous treatment.

2019 novel coronavirus: Although there is no specific drug, there is no specific treatment, but many symptoms can be symptomatic treatment, can effectively reduce the patient's condition. Patients can effectively fight against the new coronavirus by strengthening their immunity, and the treatment cycle is much shorter than that of tuberculosis.

\7. prevention

No matter what kind of disease, early detection, early report, early diagnosis, early isolation and early treatment are very effective prevention and control methods.

First, cut off the transmission channels. Do not spit everywhere, cover your mouth and nose with a handkerchief or elbow or wear a mask when sneezing or coughing, disinfect and clean the patient's articles in time, keep good personal hygiene habits, and wash hands frequently.

Second, control the source of infection. Isolation measures shall be taken for infectious patients and they shall actively cooperate with the treatment.

Third, protect vulnerable groups. Strengthening exercise, regular work and rest, healthy diet and improving self immunity are important means to avoid infection. It can effectively reduce the risk of infection and prevent respiratory infectious diseases by strengthening the ventilation and air circulation through windows and reducing the density of space bacteria.

It has been proved by medical research that the peptide molecules contained in peptide drugs are helpful for the treatment of tuberculosis. The bioactive substances contained in peptide drugs can improve the cellular immune function of human body in varying degrees, and the treatment of tuberculosis is more efficient and safer.

Shengnuobi has been committed to the research of peptide drugs. It not only has Chengdu municipal "Chengdu peptide drug engineering technology research center", 0 defect has passed the FDA certification, but also has become the first-class professional peptide drugs and product development, technology transfer, technology service, large-scale production and export of peptide drugs Industrial Park in China.

Shengnuo bio PRODUCT

Best sales manager contact

About Shengnuo

Chengdu Shengnuo Biotechnology Co., Ltd. has "Chengdu polypeptide drug engineering technology research center" in Chengdu, mainly engaged in polypeptide, polypeptide drug and beauty peptide research. Our zero defect has passed the FDA certification, and now it has become the first-class professional peptide drug and product development, technology transfer, technical service and peptide drug industry in the scale production and export of China's parks.